Cargando…

Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma

BACKGROUND: Radiotherapy plays a major role in the management of high grade glioma. However, the radioresistance of glioma cells limits its efficiency and drives recurrence inside the irradiated tumor volume leading to poor outcome for patients. Stereotactic hypofractionated radiotherapy is one opti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biau, Julian, Chautard, Emmanuel, De Koning, Leanne, Court, Frank, Pereira, Bruno, Verrelle, Pierre, Dutreix, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534104/ https://www.ncbi.nlm.nih.gov/pubmed/28754127 http://dx.doi.org/10.1186/s13014-017-0858-0

Ejemplares similares

Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models
por: Biau, Julian, et al.
Publicado: (2019)

Global Conservation of Protein Status between Cell Lines and Xenografts()
por: Biau, Julian, et al.
Publicado: (2016)

Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting
por: Biau, Julian, et al.
Publicado: (2019)

A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma()
por: Biau, Julian, et al.
Publicado: (2014)

Transcriptional alterations in glioma result primarily from DNA methylation–independent mechanisms
por: Court, Franck, et al.
Publicado: (2019)

Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs
por: Martin, Fanny, et al.
Publicado: (2016)

Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors
por: Leyrat, Brice, et al.
Publicado: (2022)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locus
por: Pinson, Marie-Elisa, et al.
Publicado: (2022)

Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma
por: Hayashi, Akiko, et al.
Publicado: (2020)

Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy
por: Moreau, Juliette, et al.
Publicado: (2018)

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
por: Reynaud, Thomas, et al.
Publicado: (2018)

Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage
por: Le Boiteux, Elisa, et al.
Publicado: (2021)

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report
por: Biau, J., et al.
Publicado: (2017)

The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation
por: Le Boiteux, Elisa, et al.
Publicado: (2022)

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
por: Navarria, Pierina, et al.
Publicado: (2016)

Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: A systematic review and meta-analysis
por: Park, Jaehyeon, et al.
Publicado: (2020)

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial
por: Biau, Julian, et al.
Publicado: (2020)

301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
por: Valente, A.C., et al.
Publicado: (2022)

Linear Accelerator-Based Stereotactic Radiotherapy for Low-Grade Meningiomas: Improved Local Control With Hypofractionation
por: Wegner, Rodney E, et al.
Publicado: (2019)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

DTI Abnormalities Related to Glioblastoma: A Prospective Comparative Study with Metastasis and Healthy Subjects
por: El Ouadih, Youssef, et al.
Publicado: (2022)

Bases physiques de la radiothérapie et de la radiobiologie
por: Tubiana, Maurice, et al.
Publicado: (1963)

Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy
por: Alaghband, Yasaman, et al.
Publicado: (2023)

Back to the future--radiotherapy in high grade gliomas.
por: Brada, M.
Publicado: (1989)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Image Fusion for Radiosurgery, Neurosurgery and Hypofractionated Radiotherapy
por: Inoue, Hiroshi K, et al.
Publicado: (2015)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis, Theodora A, et al.
Publicado: (2015)

Hypofractionated radiotherapy to treat acne keloidalis nuchae
por: Kwan, Jennifer Yin Yee, et al.
Publicado: (2021)

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience
por: Guan, Yun, et al.
Publicado: (2021)

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
por: Cha, Jihye, et al.
Publicado: (2014)

Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment
por: Wolny-Rokicka, Edyta, et al.
Publicado: (2018)

Multifocal high-grade glioma radiotherapy safety and efficacy
por: Fleischmann, Daniel Felix, et al.
Publicado: (2021)

Predicting regrowth of low-grade gliomas after radiotherapy
por: Plaszczynski, Stéphane, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q28mh22b4grgqbg44kujj7aa2h